Skip to main content
Top
Published in: AIDS and Behavior 7/2013

Open Access 01-09-2013 | Brief Report

HIV Test Avoidance Among People Who Inject Drugs in Thailand

Authors: Lianping Ti, Kanna Hayashi, Karyn Kaplan, Paisan Suwannawong, Evan Wood, Julio Montaner, Thomas Kerr

Published in: AIDS and Behavior | Issue 7/2013

Login to get access

Abstract

Case identification is a key component of HIV prevention efforts; yet rates of HIV testing remain low in some settings. We explored factors associated with HIV test avoidance among people who inject drugs (IDU) in Thailand. Between July and October 2011, 350 Thai IDU participated in the study. In bivariate analyses, male gender, high intensity drug use, syringe sharing, increased police presence, and being refused healthcare services were positively associated with HIV test avoidance, while ever receiving a hepatitis C test was negatively associated. Our findings highlight the need for interventions to reduce stigma in this setting.
Literature
1.
go back to reference Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45.PubMedCrossRef Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45.PubMedCrossRef
2.
go back to reference Ministry of Public Health Thailand. Thailand Health Profile, 2008–2010. Bangkok: Ministry of Public Health Thailand; 2011. Ministry of Public Health Thailand. Thailand Health Profile, 2008–2010. Bangkok: Ministry of Public Health Thailand; 2011.
3.
go back to reference Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva: UNAIDS; 2010. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva: UNAIDS; 2010.
4.
go back to reference WHO, UNODC. Guidance on testing and counselling for HIV in settings attended by people who inject drugs: improving access to treatment, care and prevention. Geneva: WHO; 2009. WHO, UNODC. Guidance on testing and counselling for HIV in settings attended by people who inject drugs: improving access to treatment, care and prevention. Geneva: WHO; 2009.
5.
go back to reference Girardi E, Sabin C, Monforte A. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr. 2007;46:S3–8.PubMedCrossRef Girardi E, Sabin C, Monforte A. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr. 2007;46:S3–8.PubMedCrossRef
6.
go back to reference Human Rights Watch, Thai AIDS treatment action group. Deadly denial: barriers to HIV/AIDS treatment for people who use drugs in Thailand. Thailand; 2007. Report no: 17. Human Rights Watch, Thai AIDS treatment action group. Deadly denial: barriers to HIV/AIDS treatment for people who use drugs in Thailand. Thailand; 2007. Report no: 17.
7.
go back to reference Chan K, Stoove M, Sringernyuang L, Reidpath D. Stigmatization of AIDS Patients: disentangling thai nursing students’ attitudes towards hiv/aids, drug use, and commercial sex. AIDS Behav. 2008;12:146–57.PubMedCrossRef Chan K, Stoove M, Sringernyuang L, Reidpath D. Stigmatization of AIDS Patients: disentangling thai nursing students’ attitudes towards hiv/aids, drug use, and commercial sex. AIDS Behav. 2008;12:146–57.PubMedCrossRef
8.
go back to reference Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007;18(5):352–8.PubMedCrossRef Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007;18(5):352–8.PubMedCrossRef
9.
go back to reference Ford K, Wirawan D, Sumantera G, Sawitri A, Stahre M. Voluntary HIV testing, disclosure, and stigma among injection drug users in Bali. Indonesia. AIDS Educ Prev. 2004;16(6):487–98.CrossRef Ford K, Wirawan D, Sumantera G, Sawitri A, Stahre M. Voluntary HIV testing, disclosure, and stigma among injection drug users in Bali. Indonesia. AIDS Educ Prev. 2004;16(6):487–98.CrossRef
11.
go back to reference Hayashi K, Milloy M, Fairbairn N, Kaplan K, Suwannawong P, Lai C, et al. Incarceration experiences among a community-recruited sample of injection drug users in Bangkok, Thailand. BMC Public Health. 2009;9(492). Hayashi K, Milloy M, Fairbairn N, Kaplan K, Suwannawong P, Lai C, et al. Incarceration experiences among a community-recruited sample of injection drug users in Bangkok, Thailand. BMC Public Health. 2009;9(492).
12.
go back to reference Hayashi K, Montaner J, Kaplan K, Suwannawong P, Wood E, Qi J, et al. Low uptake of hepatitis C testing and high prevalence of risk behaviour among HIV-positive injection drug users in Bangkok, Thailand. J Acquir Immune Defic Syndr. 2011;56(5):e133–5.PubMedCrossRef Hayashi K, Montaner J, Kaplan K, Suwannawong P, Wood E, Qi J, et al. Low uptake of hepatitis C testing and high prevalence of risk behaviour among HIV-positive injection drug users in Bangkok, Thailand. J Acquir Immune Defic Syndr. 2011;56(5):e133–5.PubMedCrossRef
Metadata
Title
HIV Test Avoidance Among People Who Inject Drugs in Thailand
Authors
Lianping Ti
Kanna Hayashi
Karyn Kaplan
Paisan Suwannawong
Evan Wood
Julio Montaner
Thomas Kerr
Publication date
01-09-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 7/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-012-0347-2

Other articles of this Issue 7/2013

AIDS and Behavior 7/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.